Literature DB >> 34233920

Classification of Uremic Toxins and Their Role in Kidney Failure.

Mitchell H Rosner1, Thiago Reis2,3, Faeq Husain-Syed4, Raymond Vanholder5, Colin Hutchison6,7, Peter Stenvinkel8, Peter J Blankestijn9, Mario Cozzolino10, Laurent Juillard11,12, Kianoush Kashani13, Manish Kaushik14, Hideki Kawanishi15, Ziad Massy16,17, Tammy Lisa Sirich18,19, Li Zuo20, Claudio Ronco21,22.   

Abstract

Advances in our understanding of uremic retention solutes, and improvements in hemodialysis membranes and other techniques designed to remove uremic retention solutes, offer opportunities to readdress the definition and classification of uremic toxins. A consensus conference was held to develop recommendations for an updated definition and classification scheme on the basis of a holistic approach that incorporates physicochemical characteristics and dialytic removal patterns of uremic retention solutes and their linkage to clinical symptoms and outcomes. The major focus is on the removal of uremic retention solutes by hemodialysis. The identification of representative biomarkers for different classes of uremic retention solutes and their correlation to clinical symptoms and outcomes may facilitate personalized and targeted dialysis prescriptions to improve quality of life, morbidity, and mortality. Recommendations for areas of future research were also formulated, aimed at improving understanding of uremic solutes and improving outcomes in patients with CKD.
Copyright © 2021 by the American Society of Nephrology.

Entities:  

Keywords:  classification; definition; dialysis; middle molecule; uremia

Year:  2021        PMID: 34233920      PMCID: PMC8729494          DOI: 10.2215/CJN.02660221

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  68 in total

1.  The glomerular filtration rate in an apparently healthy population and its relation with cardiovascular mortality during 10 years.

Authors:  Wim Van Biesen; Dirk De Bacquer; Francis Verbeke; Joris Delanghe; Norbert Lameire; Raymond Vanholder
Journal:  Eur Heart J       Date:  2007-01-12       Impact factor: 29.983

2.  Pore size--a key property for selective toxin removal in blood purification.

Authors:  Stephan Harm; Dieter Falkenhagen; Jens Hartmann
Journal:  Int J Artif Organs       Date:  2014-09-23       Impact factor: 1.595

3.  The impact of beta2-microglobulin clearance on the risk factors of cardiovascular disease in hemodialysis patients.

Authors:  Takahiro Kuragano; Aritoshi Kida; Minoru Furuta; Masayoshi Nanami; Yoshinaga Otaki; Yukiko Hasuike; Hiroshi Nonoguchi; Takeshi Nakanishi
Journal:  ASAIO J       Date:  2010 Jul-Aug       Impact factor: 2.872

4.  Reconciling and Closing the Loop Between Evidence-Based and Practice-Based Medicine: The Case for Hemodiafiltration.

Authors:  Bernard Canaud; Peter J Blankestijn; Andrew Davenport; Michiel L Bots
Journal:  Am J Kidney Dis       Date:  2016-08       Impact factor: 8.860

Review 5.  Why choose high volume online post-dilution hemodiafiltration?

Authors:  Carlo Basile; Andrew Davenport; Peter J Blankestijn
Journal:  J Nephrol       Date:  2016-09-01       Impact factor: 3.902

6.  Chronic kidney disease and risk of death from infection.

Authors:  Henry E Wang; Christopher Gamboa; David G Warnock; Paul Muntner
Journal:  Am J Nephrol       Date:  2011-08-22       Impact factor: 3.754

7.  Metabolite profiling identifies markers of uremia.

Authors:  Eugene P Rhee; Amanda Souza; Laurie Farrell; Martin R Pollak; Gregory D Lewis; David J R Steele; Ravi Thadhani; Clary B Clish; Anna Greka; Robert E Gerszten
Journal:  J Am Soc Nephrol       Date:  2010-04-08       Impact factor: 10.121

8.  Collection of daily patient reported outcomes is feasible and demonstrates differential patient experience in chronic kidney disease.

Authors:  Zoe C L Pittman; Stephen G John; Chris W McIntyre
Journal:  Hemodial Int       Date:  2016-09-12       Impact factor: 1.812

9.  Mechanism of Prominent Trimethylamine Oxide (TMAO) Accumulation in Hemodialysis Patients.

Authors:  Xin Hai; Veeda Landeras; Mirela A Dobre; Peter DeOreo; Timothy W Meyer; Thomas H Hostetter
Journal:  PLoS One       Date:  2015-12-09       Impact factor: 3.240

10.  Efficacy of Divinylbenzenic Resin in Removing Indoxyl Sulfate and P-Cresol Sulfate in Hemodialysis Patients: Results From an In Vitro Study and An In Vivo Pilot Trial (xuanro4-Nature 3.2).

Authors:  Maria Teresa Rocchetti; Carmela Cosola; Ighli di Bari; Stefania Magnani; Vanessa Galleggiante; Letizia Scandiffio; Giuseppe Dalfino; Giuseppe Stefano Netti; Mauro Atti; Roberto Corciulo; Loreto Gesualdo
Journal:  Toxins (Basel)       Date:  2020-03-10       Impact factor: 4.546

View more
  11 in total

1.  Lipid Profile Is Negatively Associated with Uremic Toxins in Patients with Kidney Failure-A Tri-National Cohort.

Authors:  Sam Hobson; Henriette de Loor; Karolina Kublickiene; Joachim Beige; Pieter Evenepoel; Peter Stenvinkel; Thomas Ebert
Journal:  Toxins (Basel)       Date:  2022-06-16       Impact factor: 5.075

2.  Indoxyl Sulfate Induces Oxidative Changes in Plasma and Hemolysate.

Authors:  Anna Pieniazek; Michal Kopera; Lukasz Gwozdzinski; Krzysztof Gwozdzinski
Journal:  Molecules       Date:  2022-06-15       Impact factor: 4.927

Review 3.  Short-Chain Fatty Acids in Chronic Kidney Disease: Focus on Inflammation and Oxidative Stress Regulation.

Authors:  Giorgia Magliocca; Pasquale Mone; Biagio Raffaele Di Iorio; August Heidland; Stefania Marzocco
Journal:  Int J Mol Sci       Date:  2022-05-11       Impact factor: 6.208

Review 4.  Uremic Toxins and Cardiovascular Risk in Chronic Kidney Disease: What Have We Learned Recently beyond the Past Findings?

Authors:  Carolla El Chamieh; Sophie Liabeuf; Ziad Massy
Journal:  Toxins (Basel)       Date:  2022-04-14       Impact factor: 5.075

Review 5.  Mass Transport in High-Flux Hemodialysis: Application of Engineering Principles to Clinical Prescription.

Authors:  Farzad Mohajerani; William R Clark; Claudio Ronco; Vivek Narsimhan
Journal:  Clin J Am Soc Nephrol       Date:  2022-03-11       Impact factor: 10.614

Review 6.  Involvement of Inflammasome Components in Kidney Disease.

Authors:  Ana Karina Aranda-Rivera; Anjali Srivastava; Alfredo Cruz-Gregorio; José Pedraza-Chaverri; Shrikant R Mulay; Alexandra Scholze
Journal:  Antioxidants (Basel)       Date:  2022-01-27

7.  Ventricular arrhythmias in mouse models of diabetic kidney disease.

Authors:  Kenneth R Laurita; Shenaz Khan; Tracy McMahon; Adrienne T Dennis; Vincent Li; Robert Gaivin; Hima Sapa; Ji-Dong Fu; Jeffrey R Schelling
Journal:  Sci Rep       Date:  2021-10-18       Impact factor: 4.379

8.  Gut Microbiota Dynamics and Uremic Toxins.

Authors:  Eikan Mishima; Takaaki Abe
Journal:  Toxins (Basel)       Date:  2022-02-17       Impact factor: 4.546

Review 9.  Removal of Protein-Bound Uremic Toxins Using Binding Competitors in Hemodialysis: A Narrative Review.

Authors:  Vaibhav Maheshwari; Xia Tao; Stephan Thijssen; Peter Kotanko
Journal:  Toxins (Basel)       Date:  2021-09-04       Impact factor: 4.546

Review 10.  Effects of Expanded Hemodialysis with Medium Cut-Off Membranes on Maintenance Hemodialysis Patients: A Review.

Authors:  Zhuyun Zhang; Tinghang Yang; Yupei Li; Jiameng Li; Qinbo Yang; Liya Wang; Luojia Jiang; Baihai Su
Journal:  Membranes (Basel)       Date:  2022-02-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.